Insider filing · RYTM
David W J McGirr
Director
profile →
David W J McGirr sold $4.3M of Rhythm Pharmaceuticals (RYTM)
Executed Jun 3 2025, disclosed Jun 5 2025, 2 days later.
Value, as filed
$4.3M
65,431 sh across 2 lots
Executed
Jun 3 2025
the trade date, as filed
Disclosed
Jun 5 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DMDavid W J McGirr (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Insmed Incorporated (INSM). The largest single filing was $4.3M of RYTM (65,431 sh across 2 lots, as filed), executed Jun 3 2025.
The name
RYTM
Rhythm Pharmaceuticals, Inc.
RYTM · Healthcare · 47 filings in 24 months
ticker →
Healthcare · Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United State…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→